Dimethyl Itaconate Alleviates the Inflammatory Responses of Macrophages in Sepsis
- PMID: 33029757
- DOI: 10.1007/s10753-020-01352-4
Dimethyl Itaconate Alleviates the Inflammatory Responses of Macrophages in Sepsis
Abstract
Sepsis is an inflammatory disease characterized by dysregulation of inflammation. Macrophage-mediated inflammation has been implicated in the pathophysiology of sepsis. Itaconate is a metabolite produced in activated macrophages which has anti-inflammatory activities. In the present study, we investigated the potential effects of a cell-permeable itaconate derivative dimethyl itaconate on inflammation in sepsis. We established a lipopolysaccharide (LPS)-induced septic mouse model and administered dimethyl itaconate to the septic mice. The survival rate, serum level of pro-inflammatory cytokines, and lung pathology were evaluated. We also administered dimethyl itaconate to LPS-treated bone marrow-derived macrophages (BMDMs), and measured the cytokine production and Nrf2 expression. We also evaluated the effects of dimethyl itaconate on Nrf2-deficient mice. Administration of dimethyl itaconate enhanced survival rate, decreased serum level of TNF-α and IL-6, and ameliorated lung injury in septic mice. Dimethyl itaconate also suppressed LPS-induced production of TNF-α, IL-6, and NOS2 in BMDMs. Dimethyl itaconate activated Nrf2 and promoted the expression of Nrf2 and its downstream factor HO-1 and NQO-1. The regulatory activities of dimethyl itaconate on inflammatory cytokine production, mouse survival rate were abolished in septic Nrf2-/- mice. Dimethyl itaconate suppressed the inflammatory responses of macrophages in sepsis.
Keywords: dimethyl itaconate; inflammation; macrophages; sepsis.
References
-
- Pinsky, M.R. 2004. Dysregulation of the immune response in severe sepsis. The American Journal of the Medical Sciences 328: 220–229. - DOI
-
- Fleischmann, C., A. Scherag, N.K. Adhikari, C.S. Hartog, T. Tsaganos, P. Schlattmann, D.C. Angus, K. Reinhart, and International Forum of Acute Care Trialists. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193: 259–272. - DOI
-
- Qiu, P., Y. Liu, and J. Zhang. 2019. Review: The role and mechanisms of macrophage autophagy in sepsis. Inflammation 42: 6–19. - DOI
-
- Evans, T.J. 1996. The role of macrophages in septic shock. Immunobiology 195: 655–659. - DOI
-
- Kumar, V. 2018. Targeting macrophage immunometabolism: dawn in the darkness of sepsis. International Immunopharmacology 58: 173–185. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous